AVITA Medical, Inc. (AVHHL)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Total revenues | 18,418 | 18,514 | 19,546 | |
| Cost of sales | 3,469 | 2,833 | 3,190 | |
| Gross profit | 14,949 | 15,681 | 16,356 | |
| Sales and marketing | 14,314 | 14,834 | 15,144 | |
| Research and development | 5,117 | 6,284 | 5,428 | |
| General and administrative | 6,666 | 6,390 | 9,590 | |
| Total operating expenses | 26,097 | 27,508 | 30,162 | |
| Operating loss | -11,148 | -11,827 | -13,806 | |
| Interest expense | 1,252 | 1,233 | 1,359 | |
| Other income, net | 2,484 | -791 | -1,068 | |
| Loss before income taxes | -9,916 | -13,851 | -16,233 | |
| Income tax expense | 4 | 8 | -28 | |
| Net loss | -9,920 | -13,859 | -16,205 | |
| Basic | -0.38 | -0.53 | -0.62 | |
| Diluted | -0.38 | -0.53 | -0.62 | |
| Weighted average number of shares outstanding, basic, total | 26,367,548 | 26,253,565 | 25,983,929 | |
| Weighted average number of shares outstanding, diluted, total | 26,367,548 | 26,253,565 | 25,983,929 | |